Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $279,600 (100.0% shares, 0.0% debt)

Holdings (18)

INSM INSMED INC 11.5%
Value ($000) $32,018 Shares 961,797 Est. Cost $20.81 Unrealized +75.6%
FOLD AMICUS THERAPEUTICS INC 10.9%
Value ($000) $30,372 Shares 1,315,395 Est. Cost $9.80 Unrealized +108.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 9.4%
Value ($000) $26,257 Shares 565,890 Est. Cost $24.87 Unrealized +59.7%
ACAD ACADIA PHARMACEUTICALS INC 8.6%
Value ($000) $24,074 Shares 450,317 Est. Cost $43.17 Unrealized +15.0%
TRILLIUM THERAPEUTICS INC 7.8%
Value ($000) $21,744 Shares 1,478,181 Est. Cost $4.53 Unrealized
ALLAKOS INC 7.4%
Value ($000) $20,673 Shares 147,662 Est. Cost $81.12 Unrealized
ZOGENIX INC 7.0%
Value ($000) $19,603 Shares 980,645 Est. Cost $36.29 Unrealized
AXSM AXSOME THERAPEUTICS INC 6.4%
Value ($000) $17,931 Shares 220,098 Est. Cost $80.87 Unrealized -7.5%
COGT COGENT BIOSCIENCES INC 6.3%
Value ($000) $17,507 Shares 1,558,975 Est. Cost $10.99 Unrealized 0.0%
ARGX ARGENX SE 5.3%
Value ($000) $14,690 Shares 49,950 Est. Cost $160.52 Unrealized
MIRATI THERAPEUTICS INC 4.8%
Value ($000) $13,288 Shares 60,500 Est. Cost $188.64 Unrealized
KARYOPHARM THERAPEUTICS INC 3.9%
Value ($000) $10,872 Shares 702,351 Est. Cost $18.82 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.3%
Value ($000) $9,312 Shares 215,000 Est. Cost $43.31 Unrealized
AMARIN CORP PLC 2.6%
Value ($000) $7,375 Shares 1,508,237 Est. Cost $14.78 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 2.3%
Value ($000) $6,333 Shares 150,433 Est. Cost $61.59 Unrealized -28.6%
SERES THERAPEUTICS INC 2.3%
Value ($000) $6,297 Shares 257,016 Est. Cost $24.50 Unrealized
VERONA PHARMA PLC 0.3%
Value ($000) $700 Shares 100,000 Est. Cost $6.24 Unrealized
MIRAGEN THERAPEUTICS INC 0.2%
Value ($000) $554 Shares 35,092 Est. Cost $15.79 Unrealized